您的位置: 中国博士人才网 > 博士后招收 > 海外博士后招收 > 英国牛津大学骨髓增生性肿瘤干细胞研究博士后招收

英国牛津大学骨髓增生性肿瘤干细胞研究博士后招收

时间:2013-09-30来源:博士人才网 作者:91boshi

Single-cell analysis applied to myeloproliferative neoplastic stem cells

Applications are invited for a postdoctoral position in the research group of Dr Adam Mead, based in the Haematopoietic Stem Cell Biology (HSCB) laboratory of Professor Sten Eirik Jacobsen (http://www.imm.ox.ac.uk/wimm-research/haematopoietic-stem-cell-biology/sten-eirik-waelgaard-jacobsen), which works closely with the Molecular Haematology Unit. The position is funded by Novartis Pharmaceuticals UK Limited for 3 years.

This position will especially suit candidates interested in haematopoiesis, leukaemogenesis and leukaemic stem cells, and understanding how key signalling regulators modulate the biology of haematopoietic stem/progenitor cells and their response to novel targeted therapies. The project aims to apply pioneering single cell analysis to help unravel clonal complexity in myeloproliferative neoplastic stem cells.

You will hold a PhD in a relevant area with a strong publication record in normal or malignant haematopoiesis research. Previous experience in experimental application of molecular and cellular biology techniques to the study of haematopoiesis is essential. You will have excellent interpersonal and communication skills, organizational skills to plan experimental bench-work and the ability to work as part of a team as well as independently when required.

Applications for this vacancy are to be made online. To apply for this role and for further details, including a job description and selection criteria, please click on the link below:-

https://www.recruit.ox.ac.uk/pls/hrisliverecruit/erq_jobspec_version_4.jobspec?p_id=110044

You will be required to upload a CV and supporting statement as part of your online application

The closing date for this position is noon on Friday 25 October 2013.

Committed to equality and valuing diversity

中国-博士人才网发布

声明:凡本网注明“来源:XXX”的文/图等稿件,本网转载出于传递更多信息及方便产业探讨之目的,并不意味着本站赞同其观点或证实其内容的真实性,文章内容仅供参考。

------分隔线----------------------------
博士交流群:更多>>
【01号群】52394121;【02号群】29897443;【03号群】120320822
【04号群】71153177;【05号群】75698417;【06号群】177347342
【07号群】126881746;【08号群】145243525;【09号群】202869152
隐藏
展开